Cefoxitin Injection, Powder, For Solution
Product Images NDC 0143-9878

5 FDA label images from Hikma Pharmaceuticals Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cefoxitin (NDC 0143-9878). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Cefoxitin For Injection 1)

Chemical Structure (Cefoxitin For Injection 1)
Chemical structure diagram of cefoxitin, showing its molecular framework including a beta-lactam ring, sulfur atoms, and functional groups such as methoxy and acetamido moieties.*
FDA Label Image

Cef 1g Unit (Cefoxitin For Injection 2)

Cef 1g Unit (Cefoxitin For Injection 2)
Label for Cefoxitin Injection, USP 1 g/vial, an intravenous powder for solution by Hikma Pharmaceuticals USA Inc. The label includes dosage information, storage instructions, manufacturer and distributor details, and barcodes. It specifies the product as for IV use only and prescription use only.*
FDA Label Image

Cef 1g S-p (Cefoxitin For Injection 3)

Cef 1g S-p (Cefoxitin For Injection 3)
Cefoxitin 1 g vial label for injection USP, powder for solution. The label indicates intravenous use only with a package size of 25 vials of 1 g each. Manufactured by Hikma Farmacêutica (Portugal) and distributed by West-Ward in Eatontown, NJ. Includes storage instructions and a note that the product is prescription-only (Rx only).*
FDA Label Image

Cef 2g Unit (Cefoxitin For Injection 4)

Cef 2g Unit (Cefoxitin For Injection 4)
Cefoxitin 2 g/vial injection, powder for solution, for intravenous use. The label shows the product name Cefoxitin for Injection USP, strength 2 g per vial, and includes storage instructions to keep dry material between 2°C and 25°C and avoid exposure above 50°C. Labeler information includes Hikma Farmacêutica (Portugal) and West-Ward Pharmaceutical Corp., Eatontown, NJ. The NDC code 0143-9877-01 is visible along with a barcode.*
FDA Label Image

Cef 2g S-p (Cefoxitin For Injection 5)

Cef 2g S-p (Cefoxitin For Injection 5)
Label for Cefoxitin injection powder, USP, 2 g per vial, for intravenous use. Packaging states 25 vials of 2 g each. The labeler is Hikma Pharmaceuticals USA Inc., distributed by West-Ward in Eatontown, NJ. Instructions indicate it is for prescription use only, with storage and preparation details provided.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.